Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy

Posada García, Celia; Florez Menendez, Maria Angeles; Pardavila Riveiro, Raquel; García Cruz, María Aranzazu; Amador Barciela, María Lourdes; Álvarez Martínez, Mónica; Alberte Lista, Lara Maria; Cruces Prado, Manuel José
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/22881
PMID: 19467966
ISSN: 1167-1122
ESSN: 1952-4013
Full record
Services
Services
RISMendeleyLinksolver
Files view or download
Files view or download
Date issued
2009
Journal title
European Journal of Dermatology
Type of content
Artigo
DeCS
protocolos de quimioterapia antineoplásica combinada | linfoma de células B
MeSH
Lymphoma, B-Cell | Rituximab | Antineoplastic Combined Chemotherapy Protocols
Abstract
[EN] Primary cutaneous large B-cell lymphoma, leg type (PCLBCL LT), has a poor prognosis, anthracycline containing chemotherapy being its first line treatment. During recent years rituximab therapy has also been reported, with variable but promising results. Cases of PCLBCL LT presenting with different clinical pictures and successfully treated with rituximab plus chemotherapy are reported and discussed.